Navigation Links
Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008
Date:8/31/2010

NEW YORK, Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Global Orthobiologics Market - Players, products and technologies driving change 2008

http://www.reportlinker.com/p0192725/The-Global-Orthobiologics-Market---Players-products-and-technologies-driving-change-2008.html

The primary advantage of synthetic bone graft substitutes and growth factors compared with allograft bone tissue is that they do not depend on the availability of donated human tissue. In addition, owing to the potential risk of disease transmission, synthetic materials and growth factors may be perceived as safer than allograft-based bone tissue. Many new composite products are also becoming available which seek to harness the combined characteristics of synthetic and natural materials in one single product optimised for rapid bone repair and regeneration.

Stem cell therapy is also showing huge potential as an alternative to autograft. Mesenchymal stem cells (MSCs) found in bone marrow, can form a variety of cells in the laboratory, including fat cells, cartilage, bone, tendon and ligaments, muscles cells, skin cells and even nerve cells. Unlike most other human adult stem cells, MSCs can be obtained in quantities appropriate for clinical applications, making them good candidates for use in tissue repair. They also offer the advantage of low morbidity and cost.

The last twelve months has seen consolidation in the orthobiologic sector, although most of the acquisitions have been relatively small in terms of money. The largest acquisition, and of particular interest, is the rather surprising entry into the segment of negative-pressure woundcare company, Kinetic Concepts, with its proposed acquisition of LifeCell, a leading provider of biological products for soft tissue repair, for US$1.7 billion.

The emergence of gene therapy?

Gene therapy has the potential to provide the ideal solution for treating a variety of musculoskeletal disorders. The promise of gene therapy is the ability to efficiently transfer new genetic material into patient cells to either replace defective genes or introduce therapeutic genes in order to treat disease.

To date, much of the research in gene therapy for the enhancement of spine fusion has centred on the transfer of genes-encoding BMPs and related proteins. Recombinant, osteogenic growth factors are now available to enhance bone repair, particularly in those applications related to the treatment of fracture non-unions and the enhancement of fusion of the spine. However, there is concern that a single dose of an exogenous protein will not induce an adequate osteogenic signal in many patients, particularly in those cases where there is a compromise of host bone and the surrounding soft tissue.

Questions answered

What will the value of stem cell therapies be in 2012?

What are the market growth drivers for the allograft tissue market?

What are the advantages and disadvantages of platelet-derived growth factors?

The synthetic bone graft market was estimated to be worth US$250 million in 2007. By what annual rate is it expected to grow over the next 5 years?

Who are the companies with novel technology in the soft tissue repair area?

What is DePuy's product line-up in the orthobiologics sector?

What is Genzyme's interest in China?

With which Australian company did Smith & Nephew sign a distribution deal in March 2008?

To understand the market and the leading companies that are driving growth and innovation you need this report

The Global Market for Orthobiologics:

Players, products and technologies driving change

Volume I:

Market Sectors

Volume I of the report looks more closely at the issues and markets as a whole and focuses on current and novel development in the following key sectors:

Allograft Tissue

Demineralised Bone Matrix

Growth Factors

Synthetic Bone Graft

Stem Cell Therapy

Joint Fluid Therapy

Cartilage Repair

Market estimates for orthobiologics materials vary greatly because the orthobiologics market is not clearly defined. Some estimates include only bone substitute materials, whereas this report also includes hyaluronic acid injections for joint fluid therapy and articular cartilage repair products.

The global orthobiologics market was estimated by Espicom to be worth US$4.2 billion in 2007 and accounted for 13% of the US$33 billion total orthopaedic market. With an annual growth rate of 17%, orthobiologics is the fastest growing orthopaedic segment.

The global orthobiologics market is projected to almost double by 2012, driven by technological advances and an ageing, increasingly active population giving rise to more people aged over 60 diagnosed with musculoskeletal conditions. Stem-cell therapies are forecast to be the fastest-growing category, with a CAGR of 53.9% over the next five years.

Volume II:

Company Analysis

Volume II of the report provides extensive company information on over 50 leading companies focusing on:

Product Portfolio

Research Programmes

Who's Working with Whom?

While the large multinationals have a significant presence, the orthobiologics segment is very fragmented and is mainly inhabited by much smaller companies, many of which have products that are only in the early stages of development. The orthobiologics market is currently led by Medtronic which has an expanding orthobiologics portfolio, the lead product of which is the company's InFUSE Bone Graft, which dominates the bone morphogenic protein market with an over 90% market share.

To illustrate the corporate rationalisation of the market, in November 2007 Regeneration Technologies, Inc. (RTI), a leading processor of orthopaedic and other biologic implants, and Tutogen Medical, a leading manufacturer of sterile biological implants made from human (allograft) and animal (xenograft) tissue, announced a definitive agreement to combine the two companies in a tax-free, stock-for-stock exchange valued at US$205 million.

Among the companies covered in the report

3DM

AAP Implantate

Aastrom Biosciences

Abbott Spine

Allograft Tissue Systems Inc (ATSI)

Allosource

Alphatec Spine

Apatech

Arthro Kinetics

Berkeley Advanced Biomaterials

Biomet

Biomimetic Therapeutics

Bioniche Pharma

Biosyntech

co.don AG

Collagen Matrix

CSIRO

Curasan AG

DePuy

ETEX Corporation

Exactech

Ferring Pharmaceuticals

Fidia Advanced Biopolymers

Geistlich Biomaterials

Genzyme

Graftys

Integra Lifesciences

ISTO Technologies

Kasios

Kinamed

Lifecell

Lifenet Health

Magnecell

Mica

Medtronic

Mesoblast

Nanocoatings Pty Ltd

Nanotherapeutics

Orthofix

Orthomimetics

Orthovita

Osiris

Ossacur

Osteotech

Pegasus Biologics

Regen Biologics

RTI Biologics

Smith & Nephew

Spinal Restoration

Stellar Pharmaceuticals

Stryker

Synthes

Tigenix

TRB Chemedica

Wright Medical

Zimmer

Table of Contents available upon request

To order this report:

Orthopedic Industry: The Global Orthobiologics Market - Players, products and technologies driving change 2008

Orthopedic Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

CONTACT;

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds All Change in the Coronary Stent Market
2. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
3. Reportlinker Adds Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the Key Revenue Generators
4. Reportlinker Adds Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
6. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
7. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
8. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
9. Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017
10. Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017
11. Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 2017 Systems Magnetic resonance imaging ... of the organs and tissues in the body with ... The technique does not use ionizing radiation either for ... growth of cancer. MRI is used for a variety ... and orthopedics. Hence, MRI helps in the diagnosis and ...
(Date:2/20/2017)... Feb. 20, 2017  Henry Schein, Inc. (Nasdaq: HSIC), ... products and services to office-based dental, animal ... it has entered into an agreement to ... leading U.S. distributor of anesthesia and surgical ... periodontists. SAS offers controlled and non-controlled pharmaceuticals, ...
(Date:2/20/2017)...  National Decision Support Company (NDSC) announces its ... Imaging platform within the full range of MEDITECH ... foundation for MEDITECH sites, through a directly supported ... Support Mechanism through the MEDITECH EHR. ... the integration of NDSC,s mechanism, which enables provider ...
Breaking Medicine Technology:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... Chuck E. ... Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, ... other special needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s ...
(Date:2/19/2017)... Carolina (PRWEB) , ... February 19, 2017 , ... The ... evening undergraduate nursing students, is being led by Amelia Joseph, Ph.D. Joseph was engaged ... initial operations of the nursing department in early 2016. After a nation-wide search, she ...
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic ... MEDfx and the Delaware Health Information Network (DHIN) have partnered to improve connectivity ... state-wide health information exchange, DHIN stores and shares real-time health data for more ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode ... The episode, which was posted this week, features a 30-minute interview of White by ... Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of ...
Breaking Medicine News(10 mins):